This report contains market size and forecasts of Prostate Cancer Diagnosis and Therapy in Global, including the following market information:
Global Prostate Cancer Diagnosis and Therapy Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global top five companies in 2022 (%)
The global Prostate Cancer Diagnosis and Therapy market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Hormone Therapy Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Diagnosis and Therapy include AbbVie, Astellas Pharma, AstraZeneca, Bayer, Dendreon Pharmaceuticals, Ferring, Ipsen Pharma, Johnson and Johnson and Sanofi and etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prostate Cancer Diagnosis and Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Diagnosis and Therapy Market, by Type, 2018-2023, 2023-2030 ($ millions)
Global Prostate Cancer Diagnosis and Therapy Market Segment Percentages, by Type, 2022 (%)
Hormone Therapy
Chemotherapy
Biologic Therapy
Targeted Therapy
Global Prostate Cancer Diagnosis and Therapy Market, by Application, 2018-2023, 2023-2030 ($ millions)
Global Prostate Cancer Diagnosis and Therapy Market Segment Percentages, by Application, 2022 (%)
General Hospitals
Specialty Clinics
Global Prostate Cancer Diagnosis and Therapy Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions)
Global Prostate Cancer Diagnosis and Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Diagnosis and Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Prostate Cancer Diagnosis and Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Astellas Pharma
AstraZeneca
Bayer
Dendreon Pharmaceuticals
Ferring
Ipsen Pharma
Johnson and Johnson
Sanofi
Tolmar Pharmaceuticals
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Diagnosis and Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Diagnosis and Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Diagnosis and Therapy Overall Market Size
2.1 Global Prostate Cancer Diagnosis and Therapy Market Size: 2022 VS 2030
2.2 Global Prostate Cancer Diagnosis and Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Diagnosis and Therapy Players in Global Market
3.2 Top Global Prostate Cancer Diagnosis and Therapy Companies Ranked by Revenue
3.3 Global Prostate Cancer Diagnosis and Therapy Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Diagnosis and Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Diagnosis and Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Diagnosis and Therapy Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Diagnosis and Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Diagnosis and Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Prostate Cancer Diagnosis and Therapy Market Size Markets, 2022 & 2030
4.1.2 Hormone Therapy
4.1.3 Chemotherapy
4.1.4 Biologic Therapy
4.1.5 Targeted Therapy
4.2 By Type - Global Prostate Cancer Diagnosis and Therapy Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Diagnosis and Therapy Revenue, 2018-2023
4.2.2 By Type - Global Prostate Cancer Diagnosis and Therapy Revenue, 2023-2030
4.2.3 By Type - Global Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Diagnosis and Therapy Market Size, 2022 & 2030
5.1.2 General Hospitals
5.1.3 Specialty Clinics
5.2 By Application - Global Prostate Cancer Diagnosis and Therapy Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Diagnosis and Therapy Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Diagnosis and Therapy Revenue, 2023-2030
5.2.3 By Application - Global Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Prostate Cancer Diagnosis and Therapy Market Size, 2022 & 2030
6.2 By Region - Global Prostate Cancer Diagnosis and Therapy Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Diagnosis and Therapy Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Diagnosis and Therapy Revenue, 2023-2030
6.2.3 By Region - Global Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Prostate Cancer Diagnosis and Therapy Revenue, 2018-2030
6.3.2 US Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
6.3.3 Canada Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
6.3.4 Mexico Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Diagnosis and Therapy Revenue, 2018-2030
6.4.2 Germany Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
6.4.3 France Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
6.4.4 U.K. Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
6.4.5 Italy Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
6.4.6 Russia Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
6.4.8 Benelux Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Diagnosis and Therapy Revenue, 2018-2030
6.5.2 China Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
6.5.3 Japan Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
6.5.4 South Korea Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
6.5.6 India Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Prostate Cancer Diagnosis and Therapy Revenue, 2018-2030
6.6.2 Brazil Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
6.6.3 Argentina Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Diagnosis and Therapy Revenue, 2018-2030
6.7.2 Turkey Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
6.7.3 Israel Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
6.7.5 UAE Prostate Cancer Diagnosis and Therapy Market Size, 2018-2030
7 Players Profiles
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Prostate Cancer Diagnosis and Therapy Major Product Offerings
7.1.4 AbbVie Prostate Cancer Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.1.5 AbbVie Key News
7.2 Astellas Pharma
7.2.1 Astellas Pharma Corporate Summary
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma Prostate Cancer Diagnosis and Therapy Major Product Offerings
7.2.4 Astellas Pharma Prostate Cancer Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.2.5 Astellas Pharma Key News
7.3 AstraZeneca
7.3.1 AstraZeneca Corporate Summary
7.3.2 AstraZeneca Business Overview
7.3.3 AstraZeneca Prostate Cancer Diagnosis and Therapy Major Product Offerings
7.3.4 AstraZeneca Prostate Cancer Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.3.5 AstraZeneca Key News
7.4 Bayer
7.4.1 Bayer Corporate Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Prostate Cancer Diagnosis and Therapy Major Product Offerings
7.4.4 Bayer Prostate Cancer Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.4.5 Bayer Key News
7.5 Dendreon Pharmaceuticals
7.5.1 Dendreon Pharmaceuticals Corporate Summary
7.5.2 Dendreon Pharmaceuticals Business Overview
7.5.3 Dendreon Pharmaceuticals Prostate Cancer Diagnosis and Therapy Major Product Offerings
7.5.4 Dendreon Pharmaceuticals Prostate Cancer Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.5.5 Dendreon Pharmaceuticals Key News
7.6 Ferring
7.6.1 Ferring Corporate Summary
7.6.2 Ferring Business Overview
7.6.3 Ferring Prostate Cancer Diagnosis and Therapy Major Product Offerings
7.6.4 Ferring Prostate Cancer Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.6.5 Ferring Key News
7.7 Ipsen Pharma
7.7.1 Ipsen Pharma Corporate Summary
7.7.2 Ipsen Pharma Business Overview
7.7.3 Ipsen Pharma Prostate Cancer Diagnosis and Therapy Major Product Offerings
7.7.4 Ipsen Pharma Prostate Cancer Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.7.5 Ipsen Pharma Key News
7.8 Johnson and Johnson
7.8.1 Johnson and Johnson Corporate Summary
7.8.2 Johnson and Johnson Business Overview
7.8.3 Johnson and Johnson Prostate Cancer Diagnosis and Therapy Major Product Offerings
7.8.4 Johnson and Johnson Prostate Cancer Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.8.5 Johnson and Johnson Key News
7.9 Sanofi
7.9.1 Sanofi Corporate Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Prostate Cancer Diagnosis and Therapy Major Product Offerings
7.9.4 Sanofi Prostate Cancer Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.9.5 Sanofi Key News
7.10 Tolmar Pharmaceuticals
7.10.1 Tolmar Pharmaceuticals Corporate Summary
7.10.2 Tolmar Pharmaceuticals Business Overview
7.10.3 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Therapy Major Product Offerings
7.10.4 Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Therapy Revenue in Global Market (2018-2023)
7.10.5 Tolmar Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Diagnosis and Therapy Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Diagnosis and Therapy Market Drivers in Global Market
Table 3. Prostate Cancer Diagnosis and Therapy Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Diagnosis and Therapy in Global Market
Table 5. Top Prostate Cancer Diagnosis and Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Prostate Cancer Diagnosis and Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Prostate Cancer Diagnosis and Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Prostate Cancer Diagnosis and Therapy Product Type
Table 9. List of Global Tier 1 Prostate Cancer Diagnosis and Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Diagnosis and Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Prostate Cancer Diagnosis and Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Prostate Cancer Diagnosis and Therapy Revenue in Global (US$, Mn), 2023-2030
Table 14. By Application ? Global Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Prostate Cancer Diagnosis and Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Prostate Cancer Diagnosis and Therapy Revenue in Global (US$, Mn), 2023-2030
Table 17. By Region ? Global Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn), 2023-2030
Table 20. By Country - North America Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2023-2030
Table 22. By Country - Europe Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2023-2030
Table 24. By Region - Asia Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2023-2030
Table 26. By Country - South America Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2023-2030
Table 28. By Country - Middle East & Africa Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2023-2030
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Prostate Cancer Diagnosis and Therapy Product Offerings
Table 32. AbbVie Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn), (2018-2023)
Table 33. Astellas Pharma Corporate Summary
Table 34. Astellas Pharma Prostate Cancer Diagnosis and Therapy Product Offerings
Table 35. Astellas Pharma Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn), (2018-2023)
Table 36. AstraZeneca Corporate Summary
Table 37. AstraZeneca Prostate Cancer Diagnosis and Therapy Product Offerings
Table 38. AstraZeneca Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn), (2018-2023)
Table 39. Bayer Corporate Summary
Table 40. Bayer Prostate Cancer Diagnosis and Therapy Product Offerings
Table 41. Bayer Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn), (2018-2023)
Table 42. Dendreon Pharmaceuticals Corporate Summary
Table 43. Dendreon Pharmaceuticals Prostate Cancer Diagnosis and Therapy Product Offerings
Table 44. Dendreon Pharmaceuticals Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn), (2018-2023)
Table 45. Ferring Corporate Summary
Table 46. Ferring Prostate Cancer Diagnosis and Therapy Product Offerings
Table 47. Ferring Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn), (2018-2023)
Table 48. Ipsen Pharma Corporate Summary
Table 49. Ipsen Pharma Prostate Cancer Diagnosis and Therapy Product Offerings
Table 50. Ipsen Pharma Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn), (2018-2023)
Table 51. Johnson and Johnson Corporate Summary
Table 52. Johnson and Johnson Prostate Cancer Diagnosis and Therapy Product Offerings
Table 53. Johnson and Johnson Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn), (2018-2023)
Table 54. Sanofi Corporate Summary
Table 55. Sanofi Prostate Cancer Diagnosis and Therapy Product Offerings
Table 56. Sanofi Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn), (2018-2023)
Table 57. Tolmar Pharmaceuticals Corporate Summary
Table 58. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Therapy Product Offerings
Table 59. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Therapy Revenue (US$, Mn), (2018-2023)
List of Figures
Figure 1. Prostate Cancer Diagnosis and Therapy Segment by Type in 2022
Figure 2. Prostate Cancer Diagnosis and Therapy Segment by Application in 2022
Figure 3. Global Prostate Cancer Diagnosis and Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Diagnosis and Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Prostate Cancer Diagnosis and Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Diagnosis and Therapy Revenue in 2022
Figure 8. By Type - Global Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2030
Figure 10. By Region - Global Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2030
Figure 11. By Country - North America Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2030
Figure 12. US Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 13. Canada Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 14. Mexico Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 15. By Country - Europe Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2030
Figure 16. Germany Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. France Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. U.K. Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. Italy Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 20. Russia Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. Nordic Countries Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. Benelux Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. By Region - Asia Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2030
Figure 24. China Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Japan Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. South Korea Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. Southeast Asia Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 28. India Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. By Country - South America Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2030
Figure 30. Brazil Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Argentina Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. By Country - Middle East & Africa Prostate Cancer Diagnosis and Therapy Revenue Market Share, 2018-2030
Figure 33. Turkey Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 34. Israel Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Saudi Arabia Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. UAE Prostate Cancer Diagnosis and Therapy Revenue, (US$, Mn), 2018-2030
Figure 37. AbbVie Prostate Cancer Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 38. Astellas Pharma Prostate Cancer Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 39. AstraZeneca Prostate Cancer Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 40. Bayer Prostate Cancer Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 41. Dendreon Pharmaceuticals Prostate Cancer Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Ferring Prostate Cancer Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Ipsen Pharma Prostate Cancer Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Johnson and Johnson Prostate Cancer Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sanofi Prostate Cancer Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Tolmar Pharmaceuticals Prostate Cancer Diagnosis and Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
